SIC 2834 | NAICS 325412
Comprehensive research reports provide in-depth industry analysis and five-year growth forecasts, with special focus on the underlying structure and external forces and relationships that affect industries and their performance. Topics addressed in the reports include:
Monthly trade publication features news and information for drug manufacturers, with topics covered in each issue including business operations, drug development, plant floor practices, quality and risk management, compliance, and supply chain optimization, and special features including the annual "State of Pharmaceutical Manufacturing" issue. Digital editions are available online with registration.
Industry profile provides an overview of the pharmaceutical industry, with topics covered in individual chapters including improving lives of patients, improving health outcomes and driving value in health care, impact on the economy and biomedical ecosystem, research and clinical trials, and examining the promise of the drug pipeline. Current and prior reports are available for downloading free online.
Pharmaceutical companies section of this report ranks the top 20 drug manufacturers by net sales, prescriptions dispensed, and total unbranded generic prescriptions dispensed; top 20 brand name products by U.S. prescriptions; top 15 manufacturers by promotional spending; top 20 unbranded generic product manufacturers by revenue; and top 10 biologic manufacturers by annual revenue.
Series of reports examines major trends in the pharmaceutical marketplace and the challenges and opportunities that these trends present for drug manufacturers, with topics addressed in the reports including increasing incidence of chronic disease, impact of healthcare policies and payer practices, managing drug development risks vs. potential value, and growing demand in emerging economies.
Extensive selection of market research reports provides in-depth coverage, analysis, and forecasts for this product sector on a global basis, with topics covered in these publications including specific products and geographic markets, contract manufacturing organizations, product innovations, new and emerging technologies, regulatory landscape, and merger and acquisition activities and trends.
Five-year financial statement analysis includes income statements, balance sheets, and key financial ratios, with data available by sales size range on a national, state, and metro area level including:
Financial benchmarking section of these reports provides an analysis of industry profit and expenses as a percentage of revenue by major category (e.g., purchases, wages, depreciation, marketing, rent, utilities, other costs, and earnings before interest and taxes) for the most recent year and line graphs indicating trends for each category over the past five years. Sample report can be viewed free online.
Annual salary survey and online salary calculator provide base salary and total compensation data for AAPS members by highest degree attained (e.g., bachelor's, master's, PhD or PharmD), years in field, academic rank, nature of current employer, geographic region, and company size for large pharma companies. Current and prior year surveys and salary calculator are available free online.
Annual salary survey provides base salary, incentive or variable pay, and total cash compensation data for personnel employed by firms that manufacture biological and medicinal products, process botanical herbs and drugs, isolate active medicinal principals from botanical herbs and drugs, and manufacture prescription and over-the-counter pharmaceutical drugs for internal and external use.
Free online service provides salary, bonus, and hourly wage data for job positions such as research
scientist, process engineer, validation engineer, quality control technician, and sales representative,
with employers for which salary or hourly wage data is provided including Bristol-Myers Squibb Co.,
Eli Lily and Company, Merck & Co., Inc., GlaxoSmithKline, Plc, Pfizer Inc., and Johnson & Johnson.
Interactive database provides detailed transaction data for over 38,000 private and public companies sold for prices ranging from under $250,000 to over $500,000,000, with valuation measures provided including market value of invested capital as a multiple of revenue, gross profit, EBIT, EBITDA, SDE, and book value of invested capital. User guide, free webinar, and sample reports are available online.